Survival on the Fringes: How Niche Hong Kong Stocks Are Pivoting in 2026Global Report·Aug 25 at 11:33 AM01585-3.20%03933+2.50%
The Pain and Promise of Transition: Navigating a Shifting Economic EraGlobal Report·Aug 25 at 09:20 AM03933+2.50%085490.00%
UNITED LAB Expects Interim Net Profit to Drop 82% to RMB340 millionAASTOCKS News·Aug 20 at 01:32 AM03933+2.50%NVO+3.66%
Biotech Breakthroughs and Bold Pivots: Inside Lepu's Profitability and the Robotics RushGlobal Report·Aug 18 at 09:43 AM08367-3.00%02157-3.19%
United Laboratories board meets to review interim results, consider interim dividendPUBT·Aug 13 at 08:42 AM03933+2.50%
The Edge of the HKEX: Why Capital is Chasing Robots and UraniumGlobal Report·Aug 11 at 10:12 AM02432-4.87%00031+2.08%
Inside the Silent Rally of Hong Kong's Niche MedTech and Hardware PlaysGlobal Report·Aug 11 at 09:43 AM02697-1.81%09887-0.96%
The Key to Understanding the Divergence in Hong Kong Mid-Caps: Aggregation vs. CommoditizationGlobal Report·Aug 6 at 09:15 AM03933+2.50%02658+1.49%
The HK Market's Island of Misfit Toys: Who is Pivoting and Who is Sleepwalking?Global Report·Jul 29 at 09:18 AM02197+1.49%02408+0.37%
United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251Tip Ranks·Jul 16 at 04:07 AM03933+2.50%NVO+3.66%
UNITED LAB Gets Approval for New Specification of Sodium Hyaluronate Eye DropsAASTOCKS News·Jul 15 at 02:50 AM03933+2.50%
TUL wins China NMPA approval for new 0.3% sodium hyaluronate eye drops specificationPUBT·Jul 14 at 11:15 AM03933+2.50%
